menu close
dermbiont.com

DermBiont Stock

Company Profile:

DermBiont develops targeted topical therapeutics that address the root causes of skin diseases. Its pipeline includes first-in-class small molecule and biologic candidates, such as SM-020 and SM-030, designed to treat conditions like seborrheic keratoses and melasma. The company aims to revolutionize dermatology by advancing precision treatments with well-defined mechanisms of action.

Sign up for SecondMarket® to view the market and buy or sell DermBiont Stock
Buy + Sell
  • Headquarters: Boston, MA
  • Year Founded: 2019
  • Sector: Health Care
Leverage Your Equity to Help Achieve More.

DermBiont Management Team

  • Board Member

    Steven Basta

  • Board Member

    Wilder Ramsey

  • Board Member

    Daniel Yadegar

  • Co-Founder, CEO

    Karl R. Beutner

  • Co-Founder, CFO

    Nichola Eliovits

  • Chief Medical Officer

    Emma Taylor

  • Co-Founder, Chief Scientific Officer

    Robert Brucker

  • COO

    Max Dawson

Learn More About DermBiont Stock

Buy DermBiont Stock
01

DermBiont stock does not trade on public stock exchanges. DermBiont stock is considered a private security and you need to be an accredited investor to trade shares. To invest in DermBiont stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell DermBiont Stock
02

DermBiont Stock does not trade on public stock exchanges. In order to sell DermBiont shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

DermBiont Stock Price
03

DermBiont does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view DermBiont share price and other valuable private market data.

Read more about secondary market private company stock prices:

DermBiont Stock Ticker Symbol
04

There is no ticker symbol for DermBiont stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell DermBiont Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell DermBiont stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in DermBiont Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in DermBiont stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

DermBiont Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

DermBiont IPO
08

DermBiont is a private company and has not had an IPO. There is currently no DermBiont IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to DermBiont IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell DermBiont Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Color-Logo

Color Genomics

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Somatus-Logo

Somatus

Integrated care for patients with or at risk of developing kidney disease.

Cityblock Health-Logo

Cityblock Health

Tech-driven care provider for communities with complex needs.

Insitro-Logo

insitro

Drug discovery and development company.

Tonal Strong-Logo

Tonal

Developed a fitness system, called Tonal, that combines revolutionary equipment, expert-led videos, and personalized guidance into full body workouts users can do on demand from the convenience of home.

Devoted

Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

Source: Nasdaq Private Market Tape D®